BGMS Bio Green Med Solution, Inc.
Wholesale-Durable Goods, NEC · Nasdaq · SEC CIK 1130166 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY69.4%
TTM EPS YoY75.3%
Revenue 3-yr CAGR55.1%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-156.1%
Net margin-114.5%
FCF margin—
EBITDA margin-155.7%
Returns
ROE-24.2%
ROA-21.3%
ROIC (approx.)-68.7%
Asset turnover0.19x
Leverage & solvency
Liabilities / assets10.9%
Debt / equity0.00x
Current ratio6.84x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.57x
Accruals ratio-9.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $0 | $43,000 | $420,000 | $0 | $0 |
| R&D expense | $848,000 | $6.66M | $19.16M | $20.27M | $14.93M |
| SG&A expense | $7.72M | $5.39M | $6.72M | $7.38M | $7.46M |
| Operating income | -$8.43M | -$12.00M | -$25.45M | -$27.66M | -$22.39M |
| Pretax income | -$2.99M | -$11.99M | -$25.55M | -$25.91M | -$22.18M |
| Income tax | $7,000 | -$782,000 | -$3.00M | -$4.72M | -$3.73M |
| Net income | -$3.00M | -$11.21M | -$22.55M | -$21.20M | -$18.46M |
| EBITDA | -$8.42M | -$12.00M | -$25.42M | -$27.62M | -$22.35M |
| EPS (basic) | -6.45 | -502.46 | -6,419.18 | -1.90 | -2.09 |
| EPS (diluted) | -6.45 | -502.46 | -6,419.18 | -27.24 | -2.09 |
| Weighted avg. shares (diluted) | 2.19M | 22,314 | 3.54M | 11.26M | 8.93M |
| Banking | |||||
| Net interest income | $62,000 | $12,000 | — | — | — |
| Balance sheet | |||||
| Cash & equivalents | $3.50M | $3.14M | $3.38M | $18.34M | $36.56M |
| Short-term investments | — | — | — | $4.55M | $4.48M |
| Receivables | $1.26M | — | — | — | — |
| Inventory | $1.38M | — | — | — | — |
| Current assets | $6.26M | $3.67M | $7.44M | $24.41M | $40.94M |
| PP&E, net | $137,000 | $3,000 | $9,000 | $32,000 | $64,000 |
| Goodwill | $1.57M | — | — | — | — |
| Total assets | $8.19M | $4.09M | $8.80M | $28.05M | $43.14M |
| Current liabilities | $1.33M | $6.27M | $8.16M | $7.51M | $5.41M |
| Total liabilities | $1.34M | $6.27M | $8.20M | $7.62M | $5.44M |
| Shareholders' equity | $6.84M | -$2.17M | $607,000 | $15.94M | $37.69M |
| Shares outstanding | 5.40M | 36,913 | 4,412 | 628,139 | 9.99M |
| Cash flow statement | |||||
| Operating cash flow | -$4.77M | -$7.99M | -$16.11M | -$20.83M | -$18.54M |
| Capital expenditure | — | — | $6,000 | $7,000 | $27,000 |
| Free cash flow | — | — | -$16.12M | -$20.83M | -$18.57M |
| Investing cash flow | — | — | -$6,000 | -$7,000 | -$27,000 |
| Financing cash flow | $5.26M | $7.82M | $848,000 | $3.00M | $21.74M |
| Depreciation & amortization | $5,000 | $6,000 | $31,000 | $32,000 | $43,000 |
| Stock-based compensation | $2.33M | $592,000 | $1.47M | $1.51M | $1.16M |
Free plan shows the latest 5 periods; Pro shows all 28 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.